SanBio Co (TSE:4592) Receivables Turnover : 0.00 (As of Jan. 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. SanBio Co's Revenue for the three months ended in Jan. 2024 was 円0.00 Mil. SanBio Co's average Accounts Receivable for the three months ended in Jan. 2024 was 円0.00 Mil.

SanBio Co Receivables Turnover Historical Data

The historical data trend for SanBio Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Receivables Turnover Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Receivables Turnover

Get a 7-Day Free Trial

SanBio Co Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of SanBio Co's Receivables Turnover

For the Biotechnology subindustry, SanBio Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SanBio Co's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where SanBio Co's Receivables Turnover falls into.

SanBio Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

SanBio Co's Receivables Turnover for the fiscal year that ended in Jan. 2024 is calculated as

	Receivables Turnover (A: Jan. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jan. 2024 )	/ (	(Accounts Receivable (A: Jan. 2023 )	+	Accounts Receivable (A: Jan. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

SanBio Co's Receivables Turnover for the quarter that ended in Jan. 2024 is calculated as

	Receivables Turnover (Q: Jan. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jan. 2024 )	/ (	(Accounts Receivable (Q: Oct. 2023 )	+	Accounts Receivable (Q: Jan. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

SanBio Co (TSE:4592) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

SanBio Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of SanBio Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

SanBio Co (TSE:4592) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

SNBIF:USA

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines